查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1212552

免疫化学品的全球市场

Immunochemicals
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 312 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

免疫化学品的全球市场2030年将达到64亿美元

在COVID-19后改变的商务环境中，2022年42亿美元的免疫化学品的全球市场在2030年前将修正达到64亿美元的规模，在2022年到2030年间以年复合成长率5.4％增长。本报告所分析的市场区隔之一的目录抗体将记录年复合成长率4.6％，到分析期间结束时将达到42亿美元。考虑疫情后的復苏，自订抗体领域今后8年的年复合成长率将修正为6.9％。

美国市场估算为12亿美元，中国预测将以年复合成长率5.1％成长

美国的免疫化学品市场，2022年12亿美元。作为世界第2大经济大国的中国，在2022年到2030年间将以年复合成长率5.1％在2030年前将修正达到11亿美元的市场规模。其他热门的地区市场有日本和加拿大，从2022年到2030各将以4.7％和4.5％的速度成长。在欧洲市场中，德国以年复合成长率4.2％成长。

调查对像企业范例

  • Abcam Plc.
  • Agilent Research Laboratories
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • GenScript Biotech Corporation
  • PerkinElmer Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fischer Scientific Inc.

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 全球其他地区

第4章 竞争

简介目录
Product Code: MCP-6052

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Immunochemicals Market to Reach $6.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Immunochemicals estimated at US$4.2 Billion in the year 2022, is projected to reach a revised size of US$6.4 Billion by 2030, growing at aCAGR of 5.4% over the period 2022-2030. Catalog Antibodies, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$4.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Custom Antibodies segment is readjusted to a revised 6.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 5.1% CAGR

The Immunochemicals market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Select Competitors (Total 116 Featured):

  • Abcam Plc.
  • Agilent Research Laboratories
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • GenScript Biotech Corporation
  • PerkinElmer Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Immunochemicals - A Prelude
    • Recent Market Activity
    • Research Antibodies Market: Critical Role in Drug Discovery and Research
    • Key Factors Influencing Purchasing Decisions
    • Citations: One of the Key Factors Driving Research Antibodies' Purchase
    • The US Dominates the Global Immunochemicals Market
    • Emerging Markets Offer Huge Potential
    • Catalog Antibodies - The Largest Market Segment
    • Custom Antibodies: Finding Favor in Research Applications
    • Primary Antibodies Dominate the Market
    • Competitive Scenario
    • Immunochemicals - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • Abcam Plc. (UK)
    • Agilent Research Laboratories (USA)
    • Biolegend, Inc. (USA)
    • Bio-Rad Laboratories, Inc. (USA)
    • Cell Signaling Technology, Inc. (USA)
    • GenScript Biotech Corporation
    • PerkinElmer, Inc. (USA)
    • Rockland Immunochemicals, Inc. (USA)
    • Santa Cruz Biotechnology, Inc. (USA)
    • Merck (Sigma-Aldrich Corporation) (USA)
    • Thermo Fisher Scientific Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Research Funding Bolsters Market Growth
    • Chinese Market to Become the Largest Investor in Basic Research
    • Cancer Research Drives the Global Immunochemicals Market
    • Cancer Ranks Among the Top Ten Causes of Death Worldwide
    • 'Reproducibility Crisis' of Antibodies - A Major Cause of Concern
    • Proper Validation of Antibodies - Vendor Do their Part
    • New Technologies for Antibodies Validation
    • Personalized Medicine Offers New Growth Avenues
    • Rabbit Monoclonal Antibodies Score over Other Animal Antibodies
    • Researchers Prefer Commercial Research to Academic Research
    • Increasing Collaborations between Industry and Academia
    • Beckman Coulter GmbH (USA)
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Catalog Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Custom Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Immunochemicals Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 13: USA 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 16: Canada 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • JAPAN
    • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 19: Japan 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • CHINA
    • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 22: China 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • EUROPE
    • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 25: Europe 18-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 28: Europe 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • FRANCE
    • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: France 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • GERMANY
    • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: Germany 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: Italy 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: UK 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Rest of Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Rest of Europe 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Asia-Pacific Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: Asia-Pacific 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 47: Rest of World Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Rest of World Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: Rest of World 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030

IV. COMPETITION